FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and concerns a method for preparing a dry extract of goldenpert herb. The method for preparing the dry extract of herbal raw material possessing biological activity, comprising grinding goldenpert herb, extracting in 96% ethanol on a water bath, evaporating the extract, adding chloroform, removing chloroform, separating the water phase and drying under specific conditions.
EFFECT: dry extract prepared by the method described above; it is not toxic and is rich in flavonoid quercetin, and a number of the other phenolic compounds.
3 dwg, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING ANTINEOPLASTIC AND IMMUNOMODULATORY ACTION | 2013 |
|
RU2519769C1 |
MEANS, POSSESSING ANTI-TUBERCULOSIS ACTION | 2014 |
|
RU2549477C1 |
AGENT POSSESSING ANTI-INFLAMMATORY, ANTIPYRETIC AND ANTIMICROBIAL ACTION | 2013 |
|
RU2535155C1 |
AGENT EXHIBITING WOUND HEALING ACTIVITY | 2018 |
|
RU2714930C2 |
PRODUCT FOR TREATMENT OF TUMOR CACHEXIA | 2015 |
|
RU2578440C1 |
ANTI-TUBERCULOSIS AGENT | 2017 |
|
RU2657423C1 |
AGENT HAVING SELECTIVE ACTION ON TUMOR CELLS, ACTIVATING APOPTOSIS THEREOF AND PREVENTING FORMATION OF RESISTANCE THEREOF | 2018 |
|
RU2694547C1 |
ANTIFUNGAL ACTION AGENT AGAINST CANDIDA FUNGI | 2017 |
|
RU2657779C1 |
METHOD OF COMBINED LIVER CANCER PC-1 THERAPY IN EXPERIMENT | 2020 |
|
RU2734143C1 |
AGENT CAUSING IN VIVO EXPERIMENTS IN SUBSTITUTION OF TUMOR CONNECTIVE TISSUE AND TRANSFERRING TUMOR CELLS FROM G1 PHASE OF CELL CYCLE INTO REST STATE G0 | 2018 |
|
RU2731105C2 |
Authors
Dates
2013-05-27—Published
2012-02-15—Filed